In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedNova Ltd.

Division of Abbott Laboratories Inc.

Latest From MedNova Ltd.

Novate: Re-Newing The IVC Filter Market

Serial medtech entrepreneurs Chas Taylor and Paul Gilson founded Novate Medical Ltd. to develop a bioconvertible inferior vena cava filter – it protects patients from pulmonary embolisms during a critical interval, then integrates into the vessel wall. There is no need to retrieve it, a benefit that goes far beyond the economics of avoiding a second procedure.

Medical Device

Medtech in Ireland -- Turning Green into Gold

Despite the recent downturn in the national economy, Ireland's medical device community is on the verge of a major growth spurt. A lot of the credit goes to strong government support, particularly in the form of Enterprise Ireland, which serves as a major investor in medtech start-ups. Even with such support, Ireland's medtech start-up community faces many of the challenges that any start-up community faces. But the sector has high hopes and great ambitions. The second of a two-part series.
Europe

Ireland's Medtech Explosion

Over the last three decades, Ireland has built a robust medical device community serving large multi-national device companies, built on favorable tax policies and a strong manufacturing and engineering base. But now Ireland is trying to incubate a robust start-up community as well, focused on R&D and innovation, hoping to create the next Medtroniic or Covidien rather than simply serving the current ones.
Europe

Guidant Pioneers Stents' Move North to Carotids

Stenting moves from coronaries to carotids to do for stroke what these devices did for heart attacks. This new endovascular approach has surgeons switching, not fighting.
Medical Device Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Ireland
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • John O'Shaugnessy, CEO
  • Contact Info
  • MedNova Ltd.
    Phone: (353) 9175828
    Unit 3, IDA Enterprise Park,Tuam Road
    Galway,
    Ireland
Advertisement
Advertisement
UsernamePublicRestriction

Register